This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jaunmuktane, Z. et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature 525, 247–250 (2015)
Nyberg, F. & Hallberg, M. Growth hormone and cognitive function. Nat. Rev. Endocrinol. 9, 357–365 (2013)
Gasparini, L. & Xu, H. Potential roles of insulin and IGF-1 in Alzheimer’s disease. Trends Neurosci. 26, 404–406 (2003)
Westwood, A. J. et al. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 82, 1613–1619 (2014)
Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D. & Torres-Aleman, I. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat. Med. 8, 1390–1397 (2002)
Araki, W., Kume, H., Oda, A., Tamaoka, A. & Kametani, F. IGF-1 promotes β-amyloid production by a secretase-independent mechanism. Biochem. Biophys. Res. Commun. 380, 111–114 (2009)
Trejo, J. L., Carro, E., Garcia-Galloway, E. & Torres-Aleman, I. Role of insulin-like growth factor I signaling in neurodegenerative diseases. J. Mol. Med. (Berl.) 82, 156–162 (2004)
Mustafa, A. et al. Decreased plasma insulin-like growth factor-I level in familial Alzheimer’s disease patients carrying the Swedish APP 670/671 mutation. Dement. Geriatr. Cogn. Disord. 10, 446–451 (1999)
Tham, A. et al. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J. Neural Transm. Park. Dis. Dement. Sect. 5, 165–176 (1993)
Hainfellner, J. A. et al. Coexistence of Alzheimer-type neuropathology in Creutzfeldt–Jakob disease. Acta Neuropathol. 96, 116–122 (1998)
Greenland, S., Pearl, J. & Robins, J. M. Causal diagrams for epidemiologic research. Epidemiology 10, 37–48 (1999)
Abbott, A. The red-hot debate about transmissible Alzheimer’s. Nature 531, 294–297 (2016)
Rothman, K. J., Greenland, S. & Lash, T. L. Modern epidemiology (Lippincott Williams & Wilkins, 2008)
Hernán, M. A. & Robins, J. M. Causal Inference (Boca Raton: Chapman & Hall/CRC) (https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/) (in the press)
Author information
Authors and Affiliations
Contributions
All authors contributed to the study and to the writing of this Brief Communication Arising.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
H. Adams, H., A. Swanson, S., Hofman, A. et al. Amyloid-β transmission or unexamined bias?. Nature 537, E7–E9 (2016). https://doi.org/10.1038/nature19086
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature19086
This article is cited by
-
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone
Nature (2018)
-
Voltammetric determination of the Alzheimer’s disease-related ApoE 4 gene from unamplified genomic DNA extracts by ferrocene-capped gold nanoparticles
Microchimica Acta (2018)
-
Collinge et al. reply
Nature (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.